There are currently 8 active clinical trials seeking participants for Critical Limb Ischemia research studies. The states with the highest number of trials for Critical Limb Ischemia participants are Florida, California, Texas and Massachusetts.
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NCT05313165
Recruiting
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Gender:
All
Ages:
Between 18 years and 95 years
Trial Updated:
05/31/2024
Locations: University of California, San Diego Health, La Jolla, California +29 locations
Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
Register for Updates
Nutrition in Patient With Critical Limb Ischemia
NCT03529019
Recruiting
A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutriti... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
03/24/2024
Locations: Boston Medical Center, Boston, Massachusetts
Conditions: Critical Limb Ischemia, Malnutrition, Nutritional Supplements
Register for Updates
Trial to Assess Chelation Therapy in Critical Limb Ischemia
NCT03982693
Recruiting
TACT3a is a double blind, placebo-controlled, randomized trial to test a novel therapy, edetate disodium-based chelation of environmentally acquired toxic metals, to reduce cardiovascular events including amputation in high-risk diabetic patients.
Gender:
All
Ages:
50 years and above
Trial Updated:
02/23/2024
Locations: Mount Sinai Medical Center, Miami Beach, Florida
Conditions: Critical Limb Ischemia, Diabetes
Register for Updates
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
NCT05358353
Recruiting
This is a prospective, multicenter, single arm study designed to evaluate the safety and efficacy of the Temporary Bare Spur Stent System (Spur Stent System).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: St. Bernards Heart and Vascular, Jonesboro, Arkansas +31 locations
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
Register for Updates
MOTIV BTK Randomized Controlled Trial
NCT05406622
Recruiting
Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrapopliteal lesions.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: Adventist Health, Saint Helena, California +3 locations
Conditions: Critical Limb Ischemia
Register for Updates
CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
NCT05145478
Recruiting
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2024
Locations: Yale New Haven Health, New Haven, Connecticut
Conditions: Femoral Arterial Calcification, Peripheral Arterial Disease, Claudication, Critical Limb Ischemia
Register for Updates
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
NCT02805023
Recruiting
Evaluate the feasibility of an autologous cell preparation composed of a mixture of cells enriched for endothelial progenitor cells (EnEPCs) and multipotent adult hematopoietic stem/progenitor cells (HSPC) (BGC101), in the treatment of patients suffering from peripheral arterial disease (PAD) with critical limb ischemia (CLI) who have not responded to optimal pharmacological treatment or control of risk factors and/or had a revascularization failure, and do not have the option of further revascu... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/25/2023
Locations: University of San Francisco, San Francisco, California +4 locations
Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
Register for Updates
Serranator Recoil Study
NCT05161039
Recruiting
The study objective is to assess the ability to define and measure post treatment recoil in infrapopliteal arteries. Preliminary evidence as to the differences between serration angioplasty and standard balloon angioplasty as defined by post treatment recoil, lumen gain, and dissection will be collected.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/07/2022
Locations: Stanford University, Palo Alto, California +1 locations
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
Register for Updates